Dr. Bin Wu, MD

Dr. Wu practices at D'Ambrosio Eye Care, Inc. in Lancaster, Massachusetts.

Dr. Wu's NPI, 1437132529, was assigned on November 22, 2005. Dr. Wu holds Massachusetts license 241968.

Dr. Wu's primary practice is D'Ambrosio Eye Care, Inc., at 479 Old Union Turnpike, Lancaster, MA 01523 in Worcester County. The practice phone is (978) 537-3900.

Dr. Wu's primary practice is D'Ambrosio Eye Care, Inc. in Lancaster, Massachusetts. Dr. Wu is also affiliated with UMass Memorial Health - HealthAlliance-Clinton Hospital. Dmand AI also links Dr. Wu to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wu practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Wu's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Wu is licensed in Massachusetts.

CMS data shows 3,885 Medicare services from Dr. Wu across 18 procedure codes in 2024, for 883 Medicare patients. Medicare paid $261,532 for them.

CMS counts 883 Medicare patients who saw Dr. Wu in 2024. The largest group is 65 to 74, with 354 patients. 73% of them have high cholesterol, and 71% have high blood pressure. 28% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wu's median patient age at 69, with 56% women.

In 2024, Dr. Wu wrote 6,955 Medicare Part D claims for 1,203 patients. 74% of them were for generic drugs. CMS names the drug for 6,875 of them, across 33 drugs with 11 or more claims each, at $815,959 in total drug cost. In 2023, CMS named 5,883 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Wu for performance year 2024, reported through an alternative payment model (APM). Dr. Wu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 117 procedures of cataract surgery by Dr. Wu, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 11 papers to Dr. Wu, published from 2016 to 2024. 2017 was the busiest year, with 3. The most frequent topics are Isocitrate Dehydrogenase, Aminopyridines and Leukemia, Myeloid, Acute. Dr. Wu has published most often in Blood. Dr. Wu's most frequent co-authors are Martin S. Tallman, MD, Courtney Denton Dinardo, MD and Alan H. Shih, MD.

CMS Open Payments shows 43 general payments to Dr. Wu from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Allergan Inc. paid the most, $405. It also lists 1 research payment totaling $244 in 2019.